These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18754710)

  • 1. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
    Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y
    Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
    Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
    Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.
    Lin SF; Yu Z; Riedl C; Woo Y; Zhang Q; Yu YA; Timiryasova T; Chen N; Shah JP; Szalay AA; Fong Y; Wong RJ
    Surgery; 2007 Dec; 142(6):976-83; discussion 976-83. PubMed ID: 18063085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic vaccinia therapy of squamous cell carcinoma.
    Yu Z; Li S; Brader P; Chen N; Yu YA; Zhang Q; Szalay AA; Fong Y; Wong RJ
    Mol Cancer; 2009 Jul; 8():45. PubMed ID: 19580655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
    Frentzen A; Geissinger U; Tsoneva D; Stritzker J
    Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
    Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
    Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma.
    Belin LJ; Ady JW; Lewis C; Marano D; Gholami S; Mojica K; Eveno C; Longo V; Zanzonico PB; Chen NG; Szalay AA; Fong Y
    Surgery; 2013 Sep; 154(3):486-95. PubMed ID: 23890748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.
    Silberhumer GR; Brader P; Wong J; Serganova IS; Gönen M; Gonzalez SJ; Blasberg R; Zamarin D; Fong Y
    Mol Cancer Ther; 2010 Oct; 9(10):2761-9. PubMed ID: 20858727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective oncolytic vaccinia therapy for human sarcomas.
    He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
    J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
    Zhang Q; Liang C; Yu YA; Chen N; Dandekar T; Szalay AA
    Mol Genet Genomics; 2009 Oct; 282(4):417-35. PubMed ID: 19701652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.
    Brader P; Kelly KJ; Chen N; Yu YA; Zhang Q; Zanzonico P; Burnazi EM; Ghani RE; Serganova I; Hricak H; Szalay AA; Fong Y; Blasberg RG
    Clin Cancer Res; 2009 Jun; 15(11):3791-801. PubMed ID: 19470726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
    Hofmann E; Grummt F; Szalay AA
    Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
    Hofmann E; Weibel S; Szalay AA
    J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
    Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
    Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
    Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
    Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.
    Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ
    Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.